| 1. |
- Anav, Alessandro, et al.
(författare)
-
Spatiotemporal patterns of terrestrial gross primary production : A review
- 2015
-
Ingår i: Reviews of geophysics. - 8755-1209 .- 1944-9208. ; 53:3, s. 785-818
-
Forskningsöversikt (refereegranskat)abstract
- Great advances have been made in the last decade in quantifying and understanding the spatiotemporal patterns of terrestrial gross primary production (GPP) with ground, atmospheric, and space observations. However, although global GPP estimates exist, each data set relies upon assumptions and none of the available data are based only on measurements. Consequently, there is no consensus on the global total GPP and large uncertainties exist in its benchmarking. The objective of this review is to assess how the different available data sets predict the spatiotemporal patterns of GPP, identify the differences among data sets, and highlight the main advantages/disadvantages of each data set. We compare GPP estimates for the historical period (1990-2009) from two observation-based data sets (Model Tree Ensemble and Moderate Resolution Imaging Spectroradiometer) to coupled carbon-climate models and terrestrial carbon cycle models from the Fifth Climate Model Intercomparison Project and TRENDY projects and to a new hybrid data set (CARBONES). Results show a large range in the mean global GPP estimates. The different data sets broadly agree on GPP seasonal cycle in terms of phasing, while there is still discrepancy on the amplitude. For interannual variability (IAV) and trends, there is a clear separation between the observation-based data that show little IAV and trend, while the process-based models have large GPP variability and significant trends. These results suggest that there is an urgent need to improve observation-based data sets and develop carbon cycle modeling with processes that are currently treated either very simplistically to correctly estimate present GPP and better quantify the future uptake of carbon dioxide by the world's vegetation.
|
|
| 2. |
- Bousquet, Jean, et al.
(författare)
-
ARIA digital anamorphosis : Digital transformation of health and care in airway diseases from research to practice
- 2021
-
Ingår i: Allergy. European Journal of Allergy and Clinical Immunology. - : John Wiley & Sons. - 0105-4538 .- 1398-9995. ; 76:1, s. 168-190
-
Forskningsöversikt (refereegranskat)abstract
- Digital anamorphosis is used to define a distorted image of health and care that may be viewed correctly using digital tools and strategies. MASK digital anamorphosis represents the process used by MASK to develop the digital transformation of health and care in rhinitis. It strengthens the ARIA change management strategy in the prevention and management of airway disease. The MASK strategy is based on validated digital tools. Using the MASK digital tool and the CARAT online enhanced clinical framework, solutions for practical steps of digital enhancement of care are proposed.
|
|
| 3. |
- Bousquet, J. Jean, et al.
(författare)
-
Next-generation ARIA care pathways for rhinitis and asthma : a model for multimorbid chronic diseases
- 2019
-
Ingår i: Clinical and Translational Allergy. - : BMC. - 2045-7022. ; 9
-
Forskningsöversikt (refereegranskat)abstract
- Background: In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system into integrated care with organizational health literacy.Main body: As an example for chronic disease care, MASK (Mobile Airways Sentinel NetworK), a new project of the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative, and POLLAR (Impact of Air POLLution on Asthma and Rhinitis, EIT Health), in collaboration with professional and patient organizations in the field of allergy and airway diseases, are proposing real-life ICPs centred around the patient with rhinitis, and using mHealth to monitor environmental exposure. Three aspects of care pathways are being developed: (i) Patient participation, health literacy and self-care through technology-assisted "patient activation", (ii) Implementation of care pathways by pharmacists and (iii) Next-generation guidelines assessing the recommendations of GRADE guidelines in rhinitis and asthma using real-world evidence (RWE) obtained through mobile technology. The EU and global political agendas are of great importance in supporting the digital transformation of health and care, and MASK has been recognized by DG Sante as a Good Practice in the field of digitally-enabled, integrated, person-centred care.Conclusion: In 20 years, ARIA has considerably evolved from the first multimorbidity guideline in respiratory diseases to the digital transformation of health and care with a strong political involvement.
|
|
| 4. |
- Gong, Yuqing, et al.
(författare)
-
Establishing the suitability of model-integrated evidence to demonstrate bioequivalence for long-acting injectable and implantable drug products : Summary of workshop
- 2023
-
Ingår i: CPT. - : John Wiley & Sons. - 2163-8306. ; 12:5, s. 624-630
-
Forskningsöversikt (refereegranskat)abstract
- On November 30, 2021, the US Food and Drug administration (FDA) and the Center for Research on Complex Generics (CRCG) hosted a virtual public workshop titled "Establishing the Suitability of Model-Integrated Evidence (MIE) to Demonstrate Bioequivalence for Long-Acting Injectable and Implantable (LAI) Drug Products. " This workshop brought relevant parties from the industry, academia, and the FDA in the field of modeling and simulation to explore, identify, and recommend best practices on utilizing MIE for bioequivalence (BE) assessment of LAI products. This report summerized presentations and panel discussions for topics including challenges and opportunities in development and assessment of generic LAI products, current status of utilizing MIE, recent research progress of utilizing MIE in generic LAI products, alternative designs for BE studies of LAI products, and model validation/verification strategies associated with different types of MIE approaches.
|
|
| 5. |
- Micah, Angela E., et al.
(författare)
-
Tracking development assistance for health and for COVID-19 : a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050
- 2021
-
Ingår i: The Lancet. - : Elsevier. - 0140-6736 .- 1474-547X. ; 398:10308, s. 1317-1343
-
Forskningsöversikt (refereegranskat)abstract
- Background The rapid spread of COVID-19 renewed the focus on how health systems across the globe are financed, especially during public health emergencies. Development assistance is an important source of health financing in many low-income countries, yet little is known about how much of this funding was disbursed for COVID-19. We aimed to put development assistance for health for COVID-19 in the context of broader trends in global health financing, and to estimate total health spending from 1995 to 2050 and development assistance for COVID-19 in 2020. Methods We estimated domestic health spending and development assistance for health to generate total health-sector spending estimates for 204 countries and territories. We leveraged data from the WHO Global Health Expenditure Database to produce estimates of domestic health spending. To generate estimates for development assistance for health, we relied on project-level disbursement data from the major international development agencies' online databases and annual financial statements and reports for information on income sources. To adjust our estimates for 2020 to include disbursements related to COVID-19, we extracted project data on commitments and disbursements from a broader set of databases (because not all of the data sources used to estimate the historical series extend to 2020), including the UN Office of Humanitarian Assistance Financial Tracking Service and the International Aid Transparency Initiative. We reported all the historic and future spending estimates in inflation-adjusted 2020 US$, 2020 US$ per capita, purchasing-power parity-adjusted US$ per capita, and as a proportion of gross domestic product. We used various models to generate future health spending to 2050. Findings In 2019, health spending globally reached $8. 8 trillion (95% uncertainty interval [UI] 8.7-8.8) or $1132 (1119-1143) per person. Spending on health varied within and across income groups and geographical regions. Of this total, $40.4 billion (0.5%, 95% UI 0.5-0.5) was development assistance for health provided to low-income and middle-income countries, which made up 24.6% (UI 24.0-25.1) of total spending in low-income countries. We estimate that $54.8 billion in development assistance for health was disbursed in 2020. Of this, $13.7 billion was targeted toward the COVID-19 health response. $12.3 billion was newly committed and $1.4 billion was repurposed from existing health projects. $3.1 billion (22.4%) of the funds focused on country-level coordination and $2.4 billion (17.9%) was for supply chain and logistics. Only $714.4 million (7.7%) of COVID-19 development assistance for health went to Latin America, despite this region reporting 34.3% of total recorded COVID-19 deaths in low-income or middle-income countries in 2020. Spending on health is expected to rise to $1519 (1448-1591) per person in 2050, although spending across countries is expected to remain varied. Interpretation Global health spending is expected to continue to grow, but remain unequally distributed between countries. We estimate that development organisations substantially increased the amount of development assistance for health provided in 2020. Continued efforts are needed to raise sufficient resources to mitigate the pandemic for the most vulnerable, and to help curtail the pandemic for all. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.
|
|
| 6. |
- Olsson, Lennart, et al.
(författare)
-
The State of the World’s Arable Land
- 2023
-
Ingår i: Annual Review of Environment and Resources. - 1543-5938. ; 48, s. 451-475
-
Forskningsöversikt (refereegranskat)abstract
- For millennia, agriculture has been shaping landscapes on Earth. Technological change has increased agricultural productivity dramatically, especially in the past six decades, but also resulted in trade-offs such as land and soil degradation, emission of greenhouse gases (GHGs), and spreading of toxic substances. In this article we review the impacts of agriculture on the world’s arable land. We start by synthesizing information on the extent of arable land and associated agricultural practices, followed by a review of the state of the art of soil health and soil carbon. We review processes of land degradation, emission of GHGs, and threats to biodiversity. To conclude, we review key social and economic aspects of arable land and identify some important concerns for the future. The article ends on a positive note describing a potential new pathway for agriculture—to gradually adopt polycultures of novel perennial grain crops.
|
|
| 7. |
|
|
